Fragment HGH 176-191 is a synthetic peptide derived from the C-terminal end of the human growth hormone (HGH) molecule. Designed specifically to replicate the lipolytic (fat-burning) activity of HGH without its undesired effects, this 5 mg vial by Fragment HGH 175-191 QRP Nutrition 5 mg provides researchers with a high-purity tool to study targeted fat metabolism and body composition modulation.

What Is Fragment HGH 176-191?

Fragment 176-191 is a modified version of amino acids 176 to 191 of the full-length 191-amino-acid HGH sequence. It does not exhibit growth-promoting or insulin resistance effects like full HGH but retains powerful fat-burning properties.

Key Properties:

• Stimulates lipolysis (fat breakdown)
• Inhibits lipogenesis (fat accumulation)
• Does not increase IGF-1, avoiding unwanted tissue growth
• Exhibits minimal water retention and reduced side effects

Research-Based Benefits

Studies (primarily in animal and in vitro models) have shown that Fragment 176-191 may:

✅ Reduce abdominal and visceral fat
✅ Increase energy expenditure
✅ Enhance lipid metabolism
✅ Improve fat oxidation without altering blood sugar or insulin levels
✅ Target stubborn fat stores such as lower abdomen and thighs

QRP Nutrition 5 mg Format – Quality You Can Trust

QRP Nutrition’s Fragment 176-191 (5 mg) is formulated for laboratory and investigative use only. It is provided as a lyophilized (freeze-dried) peptide for reconstitution.

Product Specs:

• Purity: >98% (HPLC tested)
• Form: Lyophilized powder
• Quantity: 5 mg per vial
• Storage: Keep refrigerated at 2-8°C after reconstitution
• Shelf Life: 24 months (unreconstituted)

Suggested Research Protocol

⚠️ For research purposes only. Not for human consumption, medical, or veterinary use.

Reconstitution Example:

• Mix 1 mL bacteriostatic water with 5 mg Fragment 176-191 = 5 mg/mL solution

Typical Dosage Range (preclinical):

• 250–500 mcg per day, often split between morning and evening
• Duration: Research cycles typically span 4–6 weeks

Administration Route:

• Subcutaneous injection near abdominal fat stores (in model organisms)

⚠️ Known Side Effects (in preclinical settings)

While considered safer than full HGH, researchers have observed in rare instances:

• Mild irritation at injection site
• Temporary drowsiness or flushing
• No documented effect on blood glucose or IGF-1

Scientific Insight

Fragment 176-191 acts by mimicking the fat metabolism portion of HGH, but it lacks the proliferative and insulin-antagonizing effects, making it a targeted approach for fat loss research. Its selective mechanism makes it a promising tool for researchers studying obesity, metabolic syndrome, and body recomposition therapies.

Why Choose QRP Nutrition?

• High Purity Peptides: Verified by third-party laboratories
• GMP-certified manufacturing processes
• Secure, temperature-controlled shipping
• Certificate of Analysis (COA) included with each batch
• ‍ Trusted by university labs and research institutions globally

Final Thoughts

Fragment HGH 176-191 (5 mg) by QRP Nutrition provides an exciting and refined tool for investigating lipolytic signaling and localized fat metabolism. Its unique ability to promote fat burning without the drawbacks of traditional HGH makes it ideal for cutting-edge research into metabolic disorders, anti-obesity treatments, and physique optimization.

This article is for informational and research-use purposes only. Always follow ethical guidelines and applicable regulations when handling peptides.

Need articles for other QRP Nutrition peptides or stacks? Just let me know.